Topline safety and efficacy results of recently completed Phase 2 study in Korea of Pyramax or Arpycom – a fixed dose combination of pyronaridine tetraphosphate and artesunate – for Covid-19.For infectious viral load, the analysis of the high-risk…
Pyramax approved in PH for Covid-19 treatment